Back to Search Start Over

β-Amyloid in Alzheimerʼs Disease

β-Amyloid in Alzheimerʼs Disease

Authors :
Harvey B. Pollard
Eduardo Rojas
Nelson Arispe
Source :
CNS Drugs. 2:1-6
Publication Year :
1994
Publisher :
Springer Science and Business Media LLC, 1994.

Abstract

Recent evidence has been accumulating to suggest that the peptide β-amyloid may be implicated as a causative agent in Alzheimer’s disease. This compound is known to accumulate in the cerebral plaques that are characteristic of the disease. Whether β-amyloid is toxic per se is yet to be established, but several options are available which may reduce the toxicity of the agent and, thus, have potential in the treatment of Alzheimer’s disease.

Details

ISSN :
11727047
Volume :
2
Database :
OpenAIRE
Journal :
CNS Drugs
Accession number :
edsair.doi...........9e1d84f2f356ff75440a2a9acbf7d756
Full Text :
https://doi.org/10.2165/00023210-199402010-00001